跳至主要内容
临床试验/NCT05223491
NCT05223491已完成不适用

En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

Jørgen Bjerggaard Jensen11 个研究点 分布在 5 个国家目标入组 220 人开始时间: 2022年3月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
11
主要终点
Unaltered pathological T-stage

研究概览

简要总结

Aim: To compare the surgical method of En Bloc resection to the conventional transurethral resection of non-muscle invasive bladder cancer (NMIBC) in terms of complete removal of tumour, specimen quality, and pathological certainty.

Background: NMIBC is a common disease with a 5-year recurrence rate reported as high as 64%. The cornerstone in the treatment of NMIBC is transurethral resection (TURB) where the tumour is dissected in pieces, removed from the bladder, and pathologically examined for potential muscle invasion. As the tumour is fragmented before removal, the method violates basic oncological principles and compromises pathological examination. Hence, TURB is possibly part of the mechanism causing recurrences. En Bloc resection (EBR), where the tumour is removed in toto, can potentially overcome the flaws of conventional TURB, but large randomized trials are needed.

Methods: This project will be a multicentre randomised controlled clinical trial comparing EBR to conventional TURB. Patients with suspected NMIBC tumours with largest tumour diameter ≥1cm and ≤6cm will be randomised to either the intervention group, thus undergoing EBR, or the control group, undergoing conventional TURB. The investigators intend to include 220 patients in total, 110 patients in each group. The RCT will be initiated in 2022.

Perspectives: If EBR can be shown to remove bladder tumours with better pathological quality and certainty, this could potentially spare patients from undergoing surgeries in the future, thereby reducing costs for both patients and society.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Demographics: all BMI, smokers and non-smokers
  • Primary, papillary, non-solid bladder tumour visualised by flexible cystoscopy
  • Tumour diameter measured on CT-scan ≥2cm ≤6cm at largest diameter
  • Ability to fully comprehend the information provided and comply with protocol
  • Signed consent form
  • Patients with multiple tumours can be included if it seems feasible to resect them in one procedure

排除标准

  • Clinically suspected muscle invasive bladder cancer (invasion in to bladder muscle or extravesical extension visible on CT or solid tumour without papillary elements seen at cystoscopy)
  • Tumour located in a bladder diverticulum
  • Investigating physician concludes that en bloc resection is not technically possible
  • Pregnancy

研究组 & 干预措施

En Bloc

Experimental

The bladder tumour will be resected en bloc and removed in total, if possible.

干预措施: En Bloc resection (Procedure)

Conventional TURB

Active Comparator

The bladder tumour will be removed by conventional piecemeal resection.

干预措施: Conventional TURB (Procedure)

结局指标

主要结局

Unaltered pathological T-stage

时间窗: 4 months

Proportion of patients with unaltered pathological T-stage following central pathology revision, reTURB, or cystectomy compared to initial T-stage description from TURB.

次要结局

  • Recurrence free survival(4 months)
  • Detrusor muscle in specimen(Within one week from surgery)

研究者

发起方
Jørgen Bjerggaard Jensen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jørgen Bjerggaard Jensen

Professor, DMSc

Aarhus University Hospital

研究点 (11)

Loading locations...

相似试验